Biosystems International
Recent Finacing
Equity
Recent Raise
$2.7M
Biosystems International (BSI) is a France-based biotechnology company developing monoclonal antibody–based blood diagnostics for cancer, focused on novel biomarkers and a lung cancer detection test.
Highlights
Focus Areas
Biotechnology
Developer Platform
Health Care
Financials
$2.7M
Total Raised
1
Funding round